PortfoliosLab logoPortfoliosLab logo
OPRX vs. SE
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

OPRX vs. SE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in OptimizeRx Corporation (OPRX) and Sea Limited (SE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

OPRX vs. SE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
OPRX
OptimizeRx Corporation
-48.78%152.26%-66.04%-14.82%-72.95%99.33%203.41%-6.38%598.73%18.05%
SE
Sea Limited
-35.09%20.24%161.98%-22.16%-76.74%12.39%394.90%255.30%-15.08%-18.02%

Fundamentals

Market Cap

OPRX:

$121.71M

SE:

$52.96B

EPS

OPRX:

$0.27

SE:

$2.55

PE Ratio

OPRX:

23.42

SE:

32.49

PEG Ratio

OPRX:

0.04

SE:

0.15

PS Ratio

OPRX:

1.10

SE:

2.25

PB Ratio

OPRX:

0.95

SE:

4.23

Total Revenue (TTM)

OPRX:

$109.43M

SE:

$22.94B

Gross Profit (TTM)

OPRX:

$73.60M

SE:

$10.24B

EBITDA (TTM)

OPRX:

$9.05M

SE:

$2.21B

Returns By Period

In the year-to-date period, OPRX achieves a -48.78% return, which is significantly lower than SE's -35.09% return.


OPRX

1D
-2.79%
1M
-17.15%
YTD
-48.78%
6M
-69.37%
1Y
-27.48%
3Y*
-24.57%
5Y*
-34.74%
10Y*
18.92%

SE

1D
5.75%
1M
-23.64%
YTD
-35.09%
6M
-53.67%
1Y
-36.54%
3Y*
-1.46%
5Y*
-18.93%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OPRX vs. SE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OPRX
OPRX Risk / Return Rank: 2828
Overall Rank
OPRX Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
OPRX Sortino Ratio Rank: 2929
Sortino Ratio Rank
OPRX Omega Ratio Rank: 2929
Omega Ratio Rank
OPRX Calmar Ratio Rank: 3030
Calmar Ratio Rank
OPRX Martin Ratio Rank: 2727
Martin Ratio Rank

SE
SE Risk / Return Rank: 1515
Overall Rank
SE Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
SE Sortino Ratio Rank: 1414
Sortino Ratio Rank
SE Omega Ratio Rank: 1414
Omega Ratio Rank
SE Calmar Ratio Rank: 2222
Calmar Ratio Rank
SE Martin Ratio Rank: 1515
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OPRX vs. SE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for OptimizeRx Corporation (OPRX) and Sea Limited (SE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OPRXSEDifference

Sharpe ratio

Return per unit of total volatility

-0.35

-0.70

+0.35

Sortino ratio

Return per unit of downside risk

-0.03

-0.83

+0.80

Omega ratio

Gain probability vs. loss probability

1.00

0.89

+0.10

Calmar ratio

Return relative to maximum drawdown

-0.38

-0.61

+0.23

Martin ratio

Return relative to average drawdown

-0.84

-1.35

+0.51

OPRX vs. SE - Sharpe Ratio Comparison

The current OPRX Sharpe Ratio is -0.35, which is higher than the SE Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of OPRX and SE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


OPRXSEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.35

-0.70

+0.35

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.46

-0.30

-0.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.17

Sharpe Ratio (All Time)

Calculated using the full available price history

0.00

0.34

-0.34

Correlation

The correlation between OPRX and SE is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

OPRX vs. SE - Dividend Comparison

Neither OPRX nor SE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

OPRX vs. SE - Drawdown Comparison

The maximum OPRX drawdown since its inception was -99.32%, which is greater than SE's maximum drawdown of -90.51%. Use the drawdown chart below to compare losses from any high point for OPRX and SE.


Loading graphics...

Drawdown Indicators


OPRXSEDifference

Max Drawdown

Largest peak-to-trough decline

-99.32%

-90.51%

-8.81%

Max Drawdown (1Y)

Largest decline over 1 year

-72.65%

-60.22%

-12.43%

Max Drawdown (5Y)

Largest decline over 5 years

-96.10%

-90.51%

-5.59%

Max Drawdown (10Y)

Largest decline over 10 years

-96.10%

Current Drawdown

Current decline from peak

-93.59%

-77.44%

-16.15%

Average Drawdown

Average peak-to-trough decline

-60.21%

-43.35%

-16.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

32.46%

27.06%

+5.40%

Volatility

OPRX vs. SE - Volatility Comparison

OptimizeRx Corporation (OPRX) has a higher volatility of 25.16% compared to Sea Limited (SE) at 23.22%. This indicates that OPRX's price experiences larger fluctuations and is considered to be riskier than SE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


OPRXSEDifference

Volatility (1M)

Calculated over the trailing 1-month period

25.16%

23.22%

+1.94%

Volatility (6M)

Calculated over the trailing 6-month period

52.13%

36.92%

+15.21%

Volatility (1Y)

Calculated over the trailing 1-year period

79.64%

52.29%

+27.35%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

75.51%

64.23%

+11.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

114.51%

62.84%

+51.67%

Financials

OPRX vs. SE - Financials Comparison

This section allows you to compare key financial metrics between OptimizeRx Corporation and Sea Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B7.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
32.24M
6.85B
(OPRX) Total Revenue
(SE) Total Revenue
Values in USD except per share items

OPRX vs. SE - Profitability Comparison

The chart below illustrates the profitability comparison between OptimizeRx Corporation and Sea Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
74.8%
43.8%
Portfolio components
OPRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, OptimizeRx Corporation reported a gross profit of 24.10M and revenue of 32.24M. Therefore, the gross margin over that period was 74.8%.

SE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Sea Limited reported a gross profit of 3.00B and revenue of 6.85B. Therefore, the gross margin over that period was 43.8%.

OPRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, OptimizeRx Corporation reported an operating income of 8.57M and revenue of 32.24M, resulting in an operating margin of 26.6%.

SE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Sea Limited reported an operating income of 537.73M and revenue of 6.85B, resulting in an operating margin of 7.9%.

OPRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, OptimizeRx Corporation reported a net income of 5.02M and revenue of 32.24M, resulting in a net margin of 15.6%.

SE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Sea Limited reported a net income of 397.10M and revenue of 6.85B, resulting in a net margin of 5.8%.